Fundraising FoxRo
Unicorn · $7BPlug and Play VenturesSilicon Valley, US · 40 known investors
Find your way into Ro
Each arrow is one introduction. Sign up to fill in the first one.
Ask Chloe Alpert to introduce you to Zachariah Reitano
You →Chloe · together at Forbes 30 Under 30 2020 · Healthcare →Zachariah
Ask Jamie Chen to introduce you to Rob Schutz
You →Jamie · together at Nara Organics →Rob
Ask Sam Okafor to introduce you to Saman Rahmanian
You →Sam · together at Crispin Porter + Bogusky →Saman
Sign up to find every way you can get introduced to Ro
- Your email: who you already know at Ro, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ro team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ro is an online healthcare platform that connects patients with licensed providers and delivers prescription treatments, including GLP-1 medications for weight loss, ED treatments, and other health goals. The direct-to-consumer telehealth service is fully online and serves individual patients in the United States.
Also known as Ro.co · Roman · Roman Health Ventures Inc.
Founders & leadership
Investors · 40
How we know: the VCSheet dataset · Not right? Tell us
How we know: blue 9 capital's portfolio page · Not right? Tell us
How we know: BoxGroup's portfolio page · the VCSheet dataset · research · prnewswire.com · Not right? Tell us
How we know: BY Venture Partners's portfolio page · Not right? Tell us
How we know: Cade Ventures's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
.jpeg){kind=logo}
How we know: Designer Fund's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Draft Ventures Llc's portfolio page · Not right? Tell us
How we know: Evolution VC Partners's portfolio page · Not right? Tell us
How we know: FirstMark Capital's portfolio page · the VCSheet dataset · research · en.wikipedia.org · Not right? Tell us
How we know: Forerunner Ventures's portfolio page · Not right? Tell us
.png)
How we know: General Catalyst's portfolio page · research · en.wikipedia.org · Not right? Tell us
How we know: initialized.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: Manta Ray Ventures's portfolio page · Not right? Tell us
How we know: Maveron's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: sevensevensix.com · Not right? Tell us
How we know: the VCSheet dataset · research · prnewswire.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: SINEWAVE VENTURES's portfolio page · Not right? Tell us
How we know: Slow Ventures's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: Torch Capital's portfolio page · the VCSheet dataset · research · prnewswire.com · Not right? Tell us
How we know: Tq Ventures Llc's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Tusk Venture Partners's portfolio page · Not right? Tell us
How we know: Vine Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: research · prnewswire.com · Not right? Tell us
How we know: research · prnewswire.com · Not right? Tell us
How we know: open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Also in the syndicate · 5
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Company profile
researched Aug 2026Ro, legally Roman Health Ventures Inc., is an American telehealth company headquartered in New York City. Patients complete an online visit describing their health, lifestyle, medical history and symptoms; an affiliated US-licensed provider reviews the responses and prescribes treatment when appropriate, with medication shipped to the patient's home. The company describes itself as vertically integrated, connecting nationwide telehealth, diagnostics and labs, in-home care and pharmacy distribution in a single end-to-end experience from diagnosis to delivery of medication to ongoing care, offered without requiring insurance.
Ro launched in October 2017 as Roman, focused on sexual health, and renamed itself Ro in September 2018 as it added conditions such as hair loss, cold sores and premature ejaculation. It later expanded into women's health, mental health, fertility, metabolic health, dermatology and skincare, covering more than 25 conditions, and operates Ro Pharmacy, which delivers more than 1,000 generic drugs including treatments for allergies, heart disease, anxiety, depression and diabetes. Weight management is a major line: Ro began treating obesity with Gelesis100 (Plenity) and in January 2023 expanded into GLP-1 receptor agonists through its Body Program, later adding Zepbound and Wegovy through integrations with Eli Lilly's LillyDirect and Novo Nordisk.
Through acquisitions of Workpath (in-home care and diagnostics software with an API) and Kit (at-home diagnostic tests, including finger-prick blood tests and weight measurement tools), Ro also runs a business-to-business operation powering in-home care and diagnostic services for health systems, clinical trial operators, labs, digital health companies and large corporates. The company distributes its consumer experience through the web and an iOS app that supports order tracking, treatment updates, a GLP-1 insurance coverage checker and content and support.
Compiled by commissioned research from 11 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Founder mafia
3 people who came through Ro went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Ro.
Timeline · 40
launches, deals, and filingsNovo Nordisk partnered with Ro, among other telehealth providers, to offer the first FDA-approved GLP-1 medication in pill form.
Ro announced that eligible patients can access Eli Lilly's Foundayo (orforglipron) and launched the FDA-approved Zepbound KwikPen with Eli Lilly.
Novo Nordisk partnered with Ro and other telehealth providers to offer the Wegovy pill, described as the first FDA-approved GLP-1 medication in pill form.
Ro announced a diagnostic test developed with researchers to determine whether someone experiences food noise and its severity.
Ro said it had partnered with researchers to develop the RAID-FN Inventory, a diagnostic test to determine whether someone experiences food noise and its severity.
Ro announced partnerships with Charles Barkley and Serena Williams for its GLP-1 treatment program; the Williams campaign drew widespread controversy.
Ro announced partnerships with Charles Barkley and Serena Williams promoting its GLP-1 treatment program; the Williams campaign drew widespread controversy.
Ro announced it was working with Eli Lilly to offer Zepbound vials through an integration with LillyDirect.
In response to GLP-1 supply shortages, Ro launched a crowdsourced supply tracker, later adding a free tool for checking insurance coverage of GLP-1 medications.
Ro expanded obesity treatment through GLP-1 receptor agonists via its Body Program; after FDA approval in 2023 it began prescribing Zepbound to medically eligible patients.
Ro broadened its obesity offering to include GLP-1 receptor agonists through its Body Program, later adding Zepbound after FDA approval.
Ro agreed to create a registry of patients for future Alzheimer's disease research and clinical trials.
Ro reached an agreement with the National Institute on Aging to create a patient registry for future Alzheimer's disease research and clinical trials.
Ro cut 18% of its staff from a base of about 750 employees, citing the economic climate and a need to realign resources; affected employees received two months of severance and benefits and a three-year option exercise window.
Ro raised a $150 million inside round led by ShawSpring Partners and reached a $7 billion valuation.
$150M source ↗
Ro launched a digital skincare clinic offering customized dermatology telehealth visits and treatments, following Ro Mind and Ro Pharmacy.
Fierce Healthcare reported Dadi among the startups Ro acquired in the year preceding June 2022.
Ro acquired Kit, a startup offering at-home diagnostic tests including finger-prick blood tests and weight measurement tools.
Ro acquired Kit, a startup offering at-home diagnostic tests including finger prick blood tests and weight measurement tools.
Ro acquired women's reproductive health company Modern Fertility in a deal reported to be over $225 million.
$225M source ↗
Ro announced the acquisition of women's reproductive health company Modern Fertility in a deal reported at over $225 million.
$225M source ↗
Ro partnered with healthcare AI company Gauss to offer at-home COVID-19 rapid antigen tests pending FDA Emergency Use Authorization, and with Gelesis to distribute weight management treatment Plenity nationwide.
Ro completed a $500 million Series D led by General Catalyst, FirstMark Capital and TQ Ventures, with new investors including Altimeter Capital, Baupost Group and Dragoneer, bringing total funding to $876 million.
$500M source ↗
The former CEO of Ancestry.com joined Ro's board of directors.
Ro administered COVID-19 vaccinations in the homes of eligible New Yorkers, initially in select Yonkers zip codes, targeting elderly and homebound populations.
Ro partnered with healthcare AI company Gauss to offer smartphone-powered at-home COVID-19 rapid antigen tests pending FDA Emergency Use Authorization, and with Gelesis to distribute the weight management treatment Plenity nationwide.
Ro acquired Workpath, a software platform enabling on-demand in-home care and diagnostic services via API, including sending phlebotomists to patient homes for blood draws.
Ro acquired Workpath, an API-based software platform for on-demand in-home care and diagnostic services, including sending phlebotomists to patient homes for blood draws.
Ro launched free COVID-19 telehealth assessments and partnered with Uber to provide free assessments to Uber drivers.
The company renamed itself Ro and expanded treatments to hair loss, cold sores and premature ejaculation.
Reddit co-founder Alexis Ohanian added as a board director alongside the Series A round.
The company launched as Roman, offering telehealth treatment for sexual health conditions alongside a pharmacy to distribute medications.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 11
primary sources listed
- Ro: Online Healthcare - App Store - Appleapps.apple.com · web
11 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Ro do?
- Ro is a US direct-to-patient telehealth company combining online care, diagnostics, labs and pharmacy delivery.
- Who founded Ro?
- Ro was founded by Zachariah Reitano, Rob Schutz, Saman Rahmanian.
- Who are Ro's investors?
- Ro's investors include Ambush Capital, Ansa Capital, Black Jays Ventures, blue 9 capital, BoxGroup, BY Venture Partners, Cade Ventures, Chapter One and 27 more.
- Where is Ro headquartered?
- Ro is headquartered in Silicon Valley, US.